Poster Session 2

Tuesday, 7 December 2010

13:00 - 14:15

Abstract Posters 1120: Clinical immunology
 Chairpersons: Hani Ababneh and Lanny Rosenwasser
A rare case of ataxia telangiectasia in Malaysia
Bronchoalveolar lavage and serum eosinophil cationic protein levels in chronic asthma and bronchial carsinoma
Case report of relapsing polychondritis in children
Chronic eosinophilic pneumonia in patient with difficult-to-treat asthma
Clinical characteristics of eosinophilic organ involvement distinguishing from metastasis in cancer patients with eosinophilia
Expression of IL-17A and IL-17F cytokines in b lymphocytes
Opposite effect of etanercept and infliximab on the development of cutaneous vasculitis
PERIPHERAL eosinophilia
Study of IL-8 indices in elderly people with femoral neck fractures
Sulfated modification of lycium barbarum polysaccharide under microwave irradiation and their anti-HIV activities
The level of the tumor necrosis factor in patients with femoral neck fractures
Abstract Posters 1118: Drug and food allergy
 Chairpersons: Suleiman Al Hammadi and Sandra González-Díaz
Anaphylactic reaction induced by homeotoxic drug
Anaphylaxis after nasal provocation test with alternaria alternata extract
Anti-IgE antibody and food IgE-mediated diseases in severe asthmatic patients
Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity
Cisplatin administration following acute hypersensitivity to other platinum compounds: A phase II study
Clinical characteristics of ranitidine induced hypersensitivity
Cow milk sensitization in a group of egyptian allergic infants and children
Eczema induced by food allergy: Could it mimic an immune deficiency?
Effects of dietary counselling on protein intake and plasmatic protein profile in children with food allergy
Epidemiological study of food allergy in the town of constantine (Algeria)
Fixed drug eruption induced by ibuprofen and acetaminophen
Food allergy and atopic dermatitis
Frequency of immediate, late and delayed type food hypersensitivity in provocation test for egg allergy and its correlation with egg-white IgE RAST score
Interim findings from establishing the effectiveness, cost-effectiveness and safety of oral and sublingual immunotherapy for food allergy: A systematic review
Pangasius hypophthalmus hypersensitivity
Patient with peanut allergy with NEGATIVE cutaneous and IN VITRO TESTS, confirmed by ORAL CONTROLLED food challenge
Potential adverse reactions from complementary and alternative medicine (CAM) and dietary supplement (DS) in North America
The effectiveness of the measurement of total and specific IgE in diagnosis of cross allergy
The role of skin prick test in diagnosis of cross –allergy
Abstract Posters 1119: Skin and other diseases
 Chairpersons: Salem H. Al-Tamemi and Barbara Rogala
Anti-IgE (omalizumab) effective as single-drug therapy for chronic idiopathic urticaria
Comparative evaluation of epidemiological factors and complications of cataract surgery in diabetic patients versus non diabetic patients
Effect of a synbiotic mixture on atopic dermatitis in children: A randomized-controlled trial
Effectiveness of omalizumab in the treatment of cold urticaria
Efficacy of omalizumab monotherapy in the management of atopic dermatitis
Methotrexate for urticarial vasculitis and angioedema with cryoglobulinemia
Patient with vasculitic autoimmune and PRESSURE urticaria successfully treated with omalizuamb
The active form of d vitamin, calcitriol 1,25(OH)2D3 and natural PPRgamma agonist, -3 polyunsaturated fatty acids (PUFAs) might serve as a negative feedback loop to prevent excessive inflammation in patients with severe atopic dermatitis
Open-label use of Nanofiltered C1 Esterase Inhibitor (human) for Treatment or Prophylaxis of Acute Attacks of Hereditary Angioedema (HAE) in Pregnant Subjects
Open-label Use of Nanofiltered C1 Esterase Inhibitor (human) (nf-C1 INH) for the Prophylaxis of Attacks of Hereditary Angioedema (HAE) in Pediatric Subjects
Open-label use of Nanofiltered C1 Esterase Inhibitor (human) (nf-C1INH) for treatment of acute attacks of Hereditary Angioedema (HAE) in pediatric subjects
Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) for the Prophylaxis of Hereditary Angioedema (HAE) Attacks
Open-label use of nanofiltered C1 esterase inhibitor (human) for the treatment of hereditary angioedema (HAE) attacks